Literature DB >> 15849543

Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients.

Edith M Simmons1, Anthony Langone, M Tugrul Sezer, John P Vella, Peter Recupero, Jason D Morrow, T Alp Ikizler, Jonathan Himmelfarb.   

Abstract

BACKGROUND: Chronic kidney disease patients have a high prevalence of inflammation and oxidative stress, and this has been associated with the excess cardiovascular morbidity and mortality observed in this population. Because maintenance hemodialysis is ineffective in controlling these factors, we hypothesized that restoration of kidney function by transplantation would be required to improve uremic inflammation and oxidative stress.
METHODS: This was a prospective cohort study evaluating time-dependent changes in biomarkers of inflammation and oxidative stress before and after renal transplantation. Nineteen end-stage renal disease (ESRD) patients (age 38.3+/-13.7 years, 58% male, 95% white, 21% diabetic) undergoing living-donor renal transplantation were enrolled. C-reactive protein (CRP), interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-alpha, protein-associated carbonyl content, and F2-isoprostanes were assessed at 1 week pretransplantation and at 1 week and 2 months posttransplantation.
RESULTS: Pretransplant levels of the pro-inflammatory proteins IL-6, TNF-alpha, and CRP, as well as the oxidative stress markers plasma protein carbonyls and F2-isoprostanes, were significantly elevated in ESRD patients compared with healthy control subjects. We observed rapid and significant declines in all of these biomarkers after transplantation that persisted for 2 months.
CONCLUSIONS: Our findings indicate that restoration of renal function by transplantation improves the chronic inflammation and increased oxidative stress associated with uremia, which may contribute to the improved survival afforded to ESRD patients by renal transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849543     DOI: 10.1097/01.tp.0000157773.96534.29

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  39 in total

1.  Pulmonary hypertension in end-stage renal disease and post renal transplantation patients.

Authors:  Esam H Alhamad; Mohammed Al-Ghonaim; Hussam F Alfaleh; Joseph P Cal; Nazmi Said
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

2.  The role of age-related T-cell differentiation in patients with renal replacement therapy.

Authors:  Matthias Schaier; Angele Leick; Lorenz Uhlmann; Florian Kälble; Volker Eckstein; Anthony Ho; Stefan Meuer; Karsten Mahnke; Claudia Sommerer; Martin Zeier; Andrea Steinborn
Journal:  Immunol Cell Biol       Date:  2017-07-19       Impact factor: 5.126

3.  Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation.

Authors:  Yosuke Suzuki; Hiroki Itoh; Fuminori Sato; Kanako Kawasaki; Yukie Sato; Takashi Fujioka; Yuhki Sato; Keiko Ohno; Hiromitsu Mimata; Satoshi Kishino
Journal:  J Lipid Res       Date:  2013-07-04       Impact factor: 5.922

4.  Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation.

Authors:  Laura Cañas; Eva Iglesias; María Cruz Pastor; Jaume Barallat; Javier Juega; Ioana Bancu; Ricardo Lauzurica
Journal:  Int Urol Nephrol       Date:  2016-12-24       Impact factor: 2.370

5.  Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.

Authors:  Yuji Kamijo; Lixuan Wang; Akihiro Matsumoto; Takero Nakajima; Koji Hashimoto; Makoto Higuchi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Clin Exp Nephrol       Date:  2012-05-03       Impact factor: 2.801

Review 6.  T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance.

Authors:  Ruud Wj Meijers; Michiel Gh Betjes; Carla C Baan; Nicolle Hr Litjens
Journal:  World J Nephrol       Date:  2014-11-06

7.  End-stage renal disease, dialysis, kidney transplantation and their impact on CD4+ T-cell differentiation.

Authors:  Matthias Schaier; Angele Leick; Lorenz Uhlmann; Florian Kälble; Christian Morath; Volker Eckstein; Anthony Ho; Carsten Mueller-Tidow; Stefan Meuer; Karsten Mahnke; Claudia Sommerer; Martin Zeier; Andrea Steinborn
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

Review 8.  Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease.

Authors:  Daryl M Okamura; Jonathan Himmelfarb
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714

9.  The association of plasma fluorescent oxidation products and chronic kidney disease: a case-control study.

Authors:  Casey M Rebholz; Tianying Wu; L Lee Hamm; Robin Arora; Islam E Khan; Yanxi Liu; Chung-Shiuan Chen; Katherine T Mills; Stephanie Rogers; Myra A Kleinpeter; Eric E Simon; Jing Chen
Journal:  Am J Nephrol       Date:  2012-09-13       Impact factor: 3.754

Review 10.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.